跳至主要内容
临床试验/NCT03494023
NCT03494023已完成不适用

Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-Pancreatic Malignancies: A Multicenter Prospective Study

Clinical Hospital Colentina1 个研究点 分布在 1 个国家目标入组 539 人开始时间: 2018年3月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
539
试验地点
1
主要终点
Common bile duct diameter

研究概览

简要总结

The main objective of the study is to evaluate the size of the common bile duct (CBD) in a large cohort of patients with jaundice secondary to pancreatic head or distal bile duct malignancy undergoing diagnostic EUS for tissue acquisition or evaluation of resectability and to establish factors associated with a dilation of the CBD greater than 15mm.

详细描述

Rationale: The size of the common bile duct (CBD) may influence the type of stent used and the type of the procedure performed in cases of EUS-guided biliary drainage. However, no data of the size of the CBD in patients with jaundice presenting with a pancreatic head mass or with a distal cholangiocarcinoma/ carcinoma of the ampulla of Vater are available.

Objectives: To evaluate the size of the CBD in a large cohort of patients with jaundice secondary to pancreatic head or distal bile duct malignancy undergoing diagnostic EUS for tissue acquisition or evaluation of resectability and to establish factors associated with a dilation of the CBD greater than 15mm.

Study design: International prospective observational multicenter trial. Study population: Patients ≥18 years old, referred for EUS-guided tissue sampling or evaluation of resectability of a pancreatic, a distal bile duct lesion or a carcinoma of the ampulla of Vater determining obstructive jaundice.

Intervention: EUS examination Main study parameters/endpoints: measurement of the CBD in patients with an obstructive distal biliary mass. Determine the factors associated with a CBD greater than 15mm Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Measurement of the CBD during EUS examination does not add additional risks to the procedure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with jaundice and a pancreatic head mass lesion referred for EUS-guided tissue acquisition or staging
  • Patients with jaundice and a distal CBD lesion suggestive of cholangiocarcinoma or a carcinoma of the ampulla of Vater referred for EUS-guided tissue acquisition or staging
  • Serum bilirubin level ≥3 mg/dL
  • Age ≥18 years
  • Written informed consent

排除标准

  • Presence of altered anatomy from previous gastric surgery (Billroth II or Roux-en-Y anastomosis)
  • Previously performed sphincterotomy, biliary plastic stent or metal stent placement
  • Previous percutaneous drainage of the bile duct
  • Pregnancy
  • Inability to sign the informed consent

结局指标

主要结局

Common bile duct diameter

时间窗: Enrollment over 6 months

Measurement by endoscopic ultrasound in patients with malignant obstructive jaundice

次要结局

未报告次要终点

研究者

发起方
Clinical Hospital Colentina
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mihai Rimbas

Assistant Professor

Clinical Hospital Colentina

研究点 (1)

Loading locations...

相似试验